Home/ Stocks/ DYN

Dyne Therapeutics, Inc. Common Stock

DYN XNAS

$17.61 +0.07 (+0.40%) ▲ 15-min delayed

Open

$17.48

High

$17.88

Low

$17.32

Volume

1.74M

Market Cap

$2.91B

About Dyne Therapeutics, Inc. Common Stock

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 258 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-446,214,000	$-3.47
FY 2025	$0	$-446,214,000	$-3.47
Q3 2025	$0	$-108,041,000	$-0.76
Q2 2025	$0	$-110,857,000	$-0.97

Related Market News

No specific coverage for DYN yet. Check out our latest market news or earnings calendar.

Get DYN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Dyne Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.